GlassScriptPhysician profile
Tarandeep Kaur
NPI 1023203080
$1,170.41
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $248 · 2021: $68.77 · 2023: $109 · 2024: $66.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $291.46 | 2019-2024 | Shingrix, Arexvy |
| Novo Nordisk INC | $152.49 | 2019-2024 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $119.90 | 2019-2021 | |
| Pfizer INC. | $96.56 | 2019-2024 | |
| Lilly USA, LLC | $74.40 | 2019-2021 | |
| Amgen INC. | $72.13 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $65.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.59 | 2019-2020 | |
| Exact Sciences Corporation | $37.06 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.16 | 2019 | |
| Supernus Pharmaceuticals, INC. | $22.44 | 2019 | |
| Hologic Sales and Service, LLC | $19.42 | 2019 | |
| Alfasigma USA, INC. | $18.84 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.00 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $17.41 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.96 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.69 | 2019 | |
| Bausch Health US, LLC | $11.89 | 2019 | |
| Sanofi Pasteur INC. | $11.63 | 2019 | |
| Mylan Specialty L.P. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarandeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.